A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Coast Guard warns off Chinese vessel from Taiwan's restricted waters
06/19/2026 04:37 PM - Culture
Foreign minister pairs Taiwan zongzi with flavors from diplomatic allies
06/19/2026 04:07 PM - Culture
Amis DJ Dungi Sapor to tour U.K. with Indigenous vocals, electronic music
06/19/2026 03:45 PM - Politics
KMT chair says Taiwan would fight back against China attack
06/19/2026 03:29 PM - Politics
Taiwan, U.S. discuss expanding cooperation in Paraguay
06/19/2026 01:48 PM